UNC1062

structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Earp, H Shelton: 2 articles (07/2013 - 05/2013)
2.	Frye, Stephen V: 2 articles (07/2013 - 05/2013)
3.	Graham, Douglas K: 2 articles (07/2013 - 05/2013)
4.	Liu, Jing: 2 articles (07/2013 - 05/2013)
5.	Sather, Susan: 2 articles (07/2013 - 05/2013)
6.	Wang, Xiaodong: 2 articles (07/2013 - 05/2013)
7.	Yang, Chao: 2 articles (07/2013 - 05/2013)
8.	Zhang, Weihe: 2 articles (07/2013 - 05/2013)
9.	Cheng, Nancy: 1 article (07/2013)
10.	Cummings, Christopher T: 1 article (07/2013)

1.	Neoplasms (Cancer) 07/01/2013 - "When applied to live tumor cells, UNC1062 inhibited Mer phosphorylation and colony formation in soft agar. "
2.	Melanoma (Melanoma, Malignant) 05/01/2013 - "Treatment of melanoma cells with UNC1062, a novel MERTK-selective small-molecule tyrosine kinase inhibitor, reduced activation of MERTK-mediated downstream signaling, induced apoptosis in culture, reduced colony formation in soft agar, and inhibited invasion of melanoma cells. "